Optimizing Patient Selection & Stratification to Improve Success in Clinical Trials

Time: 12:00 pm
day: Day Two

Details:

What should the patient cohort selection look like to give best chance of success?
Which clinical end points to be selected to assess anti-tumor efficacy?
How can the late stage product manufacturing process look like for neoantigen programs?